Previous 10 | Next 10 |
Jazz Pharmaceuticals (NASDAQ: JAZZ ) has signed a definitive agreement under to acquire Redx Pharma's (Redx) pan-RAF inhibitor program for the potential treatment of RAF and RAS mutant tumors. More news on: Jazz Pharmaceuticals plc, Healthcare stocks news, Read more ...
DUBLIN , July 10, 2019 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company has signed a definitive agreement under which Jazz has acquired Redx Pharma's (Redx) pan-RAF inhibitor program for the potential treatment of RAF and RAS mutant tumors. Re...
Introduction Avadel Pharmaceuticals ( AVDL ) was once a niche-drug player which pursued re-certification of products marketed before the FDA required drugs to demonstrate safety for approval in 1938. Prior to this time, adulterated or mislabeled drugs were prohibited from sale by the FD...
Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday (you ca...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , iTunes...
Jazz Pharmaceuticals (NASDAQ: JAZZ ) detailed its U.S. commercial launch plan for Sunosi (solriamfetol) yesterday afternoon via a webcast. The FDA approved the dopamine and norepinephrine reuptake inhibitor in March for the treatment of excessive daytime sleepiness associated with narcol...
Jazz Pharmaceuticals plc (NASDAQ: JAZZ ) provides drugs to treat sleep disorders, blood diseases and cancers. Jazz Pharmaceuticals is a growth stock trading at value prices and would suit value-conscious investors. Financials Jazz Pharmaceuticals has produced strong growth over the last ...
Noteworthy events during the week of June 30 - July 6 for healthcare investors. More news on: Jazz Pharmaceuticals plc, Celyad SA, Array BioPharma Inc., Healthcare stocks news, , Read more ...
Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday (you ca...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , iTunes...
News, Short Squeeze, Breakout and More Instantly...
Jazz Pharmaceuticals plc Company Name:
JAZZ Stock Symbol:
NASDAQ Market:
Jazz Pharmaceuticals plc Website:
Jazz Pharmaceuticals Announces Second Quarter 2024 Financial Results and Updates 2024 Financial Guidance PR Newswire – 15% year-over-year revenue increase from combined key growth drivers: Xywav ® , Epidiolex ® and Rylaze ® – – O...
Jazz Pharmaceuticals Shareholders Elect Laura Hamill to the Company's Board of Directors at Annual General Meeting PR Newswire Ms. Hamill brings extensive experience and proven leadership focused on commercial growth and shareholder value DUBLIN , July 25, 20...
NORTHAMPTON, MA / ACCESSWIRE / July 23, 2024 / Jazz Pharmaceuticals Originally published by Jazz Pharmaceuticals In celebration of Pride Month , we were joined by Celia Sandhya Daniels (she/they) who led an insightful discussion aimed at educating, raising awareness and calling for unders...